BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1
75 results:

  • 1. Evaluating the Prognostic Factors and Survival Rates of Endometrial cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.
    Wannasin R; Thinkhamrop K; Kelly M; Likitdee N
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):671-679. PubMed ID: 38415555
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome.
    Helderman NC; Andini KD; van Leerdam ME; van Hest LP; Hoekman DR; Ahadova A; Bajwa-Ten Broeke SW; Bosse T; van der Logt EMJ; Imhann F; Kloor M; Langers AMJ; Smit VTHBM; Terlouw D; van Wezel T; Morreau H; Nielsen M
    J Mol Diagn; 2024 Feb; 26(2):106-114. PubMed ID: 38061582
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
    Wang X; Lu X; Chen J; Yi H; Lan Q
    BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data.
    Elbanna M; Pynda Y; Kalinchuk O; Rosa A; Abdel-Wahab M
    Lancet Oncol; 2023 Sep; 24(9):e376-e384. PubMed ID: 37657478
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression and Significance of MTA2 and CPNE1 in Cervical Squamous Cell Carcinoma.
    Wang L; Chen G; Zhou C; Wu C; Jiang J
    Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):569-573. PubMed ID: 37399268
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
    Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
    JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of the one-step nucleic acid amplification method for rapid detection of lymph node metastases in endometrial cancer: prospective, multicenter, comparative study.
    La Fera E; Bizzarri N; Petrecca A; Monterossi G; Dinoi G; Zannoni GF; Restaino S; Palmieri E; Mariuzzi L; Peters I; Scambia G; Fanfani F
    Int J Gynecol Cancer; 2023 Jul; 33(7):1063-1069. PubMed ID: 37105584
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Application value of Ki67 and serum CA125 in the deep myometrial invasion of endometrial adenocarcinoma.
    Qin L
    BMC Cancer; 2023 Mar; 23(1):240. PubMed ID: 36918859
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: A clinicopathological and molecular study of 18 cases.
    Lu B; Xia Y; Chen J; Tang J; Shao Y; Yu W
    Hum Pathol; 2023 May; 135():65-75. PubMed ID: 36646185
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
    Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.
    Kong W; Tu Y; Jiang P; Huang Y; Zhang J; Jiang S; Li N; Yuan R
    Int J Biol Markers; 2022 Dec; 37(4):395-403. PubMed ID: 36250543
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Periprocedural imaging compared to endometrial biopsy: is biopsy required prior to uterine artery embolisation?
    Currie BM; McLaughlin SW; Jones L; Neff P; Shlansky-Goldberg RD
    Clin Radiol; 2022 Sep; 77(9):694-700. PubMed ID: 35811155
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic significance of tumor budding, poorly differentiated cluster, and desmoplastic reaction in endometrioid endometrial carcinomas.
    Yamamoto M; Kaizaki Y; Kogami A; Hara T; Sakai Y; Tsuchida T
    J Obstet Gynaecol Res; 2021 Nov; 47(11):3958-3967. PubMed ID: 34448279
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
    Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer.
    Thurgar E; Gouldson M; Matthijsse S; Amonkar M; Marinello P; Upadhyay N; Nwankwo C; Aguiar-Ibáñez R
    J Med Econ; 2021; 24(1):675-688. PubMed ID: 33866938
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison of preoperative serum neopterin, periostin, indoleamine 2,3-dioxygenase, YKL-40, and tenascin-C levels with current tumor markers for early-stage endometrial cancer.
    Unuvar S; Melekoglu R; Turkmen NB; Yilmaz E; Yasar S; Yuce H
    Int J Gynaecol Obstet; 2021 Dec; 155(3):417-424. PubMed ID: 33660848
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size <2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study.
    Li P; Chen L; Ni Y; Liu J; Li D; Guo J; Liu Z; Jin S; Xu Y; Li Z; Wang L; Bin X; Lang J; Liu P; Chen C
    J Gynecol Oncol; 2021 Mar; 32(2):e17. PubMed ID: 33470062
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Minimally Invasive Approaches in Locally Advanced Cervical cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis.
    Ferrandina G; Gallotta V; Federico A; Fanfani F; Ercoli A; Chiantera V; Cosentino F; Turco LC; Legge F; Anchora LP; Bizzarri N; Moroni R; Macchia G; Valentini V; Scambia G
    Ann Surg Oncol; 2021 Jul; 28(7):3616-3626. PubMed ID: 33165720
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications.
    Bernatsky S; Ramsey-Goldman R; Urowitz MB; Hanly JG; Gordon C; Petri MA; Ginzler EM; Wallace DJ; Bae SC; Romero-Diaz J; Dooley MA; Peschken CA; Isenberg DA; Rahman A; Manzi S; Jacobsen S; Lim SS; van Vollenhoven R; Nived O; Kamen DL; Aranow C; Ruiz-Irastorza G; Sánchez-Guerrero J; Gladman DD; Fortin PR; Alarcón GS; Merrill JT; Kalunian KC; Ramos-Casals M; Steinsson K; Zoma A; Askanase A; Khamashta MA; Bruce I; Inanc M; Clarke AE
    Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1789-1795. PubMed ID: 32813314
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of core genes in the progression of endometrial cancer and cancer cell-derived exosomes by an integrative analysis.
    Shi S; Tan Q; Feng F; Huang H; Liang J; Cao D; Wang Z
    Sci Rep; 2020 Jun; 10(1):9862. PubMed ID: 32555395
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.